JOHNSON & JOHNSON plans to test Covid-19 Vaccine in Ages 12-18
According to a Reuters report, Johnson & Johnson is planning to start testing its experimental Covid-19 vaccine among those aged between 12 and 18 as soon as possible. The company's previous experience with the same technology in a vaccine successfully used in children could give it a leg up with regulators, it said.
"We plan to go into children as soon as we possibly can, but very carefully in terms of safety," Johnson & Johnson's Dr. Jerry Sadoff quoted as saying on Friday.
In a statement earlier, Johnson & Johnson had said that it is currently in discussions with regulators and partners regarding the inclusion of the pediatric population in its trials.
Meanwhile, drugmaker Pfizer Inc has already begun testing the Covid-19 vaccine, it is developing in partnership with Germany's BioNTech, among children as young as 12. Their vaccine uses messenger RNA (mRNA), a new technology that has yet to produce an approved vaccine.